{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:32:39Z","timestamp":1789475559071,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014461","name":"NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust\/Institute of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ejca.2020.06.005","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T06:46:54Z","timestamp":1596178014000},"page":"45-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Impact of sex and age on chemotherapy efficacy, toxicity and survival in localised oesophagogastric cancer: A pooled analysis of 3265 individual patient data from four large randomised trials (OE02, OE05, MAGIC and ST03)"],"prefix":"10.1016","volume":"137","author":[{"given":"Avani","family":"Athauda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Nankivell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth E.","family":"Langley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Alderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Allum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike I.","family":"Grabsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1496-6792","authenticated-orcid":false,"given":"Naureen","family":"Starling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2020.06.005_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2020.06.005_bib2","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1200\/JCO.2009.22.2083","article-title":"Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer","volume":"27","author":"Allum","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2020.06.005_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2020.06.005_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1470-2045(17)30043-8","article-title":"Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2\u20133 trial","volume":"18","author":"Cunningham","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2020.06.005_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejca.2017.07.013","article-title":"Sex differences in cancer risk and survival: a Swedish cohort study","volume":"84","author":"Radkiewicz","year":"2017","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2020.06.005_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1158\/1055-9965.EPI-11-0834","article-title":"Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis","volume":"21","author":"Camargo","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejca.2020.06.005_bib7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2016.04.001","article-title":"Comprehensive characterization of molecular differences in cancer between male and female patients","volume":"29","author":"Yuan","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2020.06.005_bib8","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ejca.2020.06.005_bib9","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1158\/1078-0432.CCR-06-3067","article-title":"Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity","volume":"13","author":"Prado","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2020.06.005_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0006-2952(92)90010-G","article-title":"Effect of age and gender on the activity of human hepatic CYP3A","volume":"44","author":"Hunt","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ejca.2020.06.005_bib11","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2165\/00003088-200342090-00001","article-title":"Role of red blood cells in pharmacokinetics of chemotherapeutic agents","volume":"42","author":"Schrijvers","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ejca.2020.06.005_bib12","series-title":"Stomach cancer statistics","year":"2016"},{"key":"10.1016\/j.ejca.2020.06.005_bib13","unstructured":"Oesophageal cancer incidence statistics | Cancer Research UK. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/oesophageal-cancer\/incidence#heading-One (accessed July 17, 2019)."},{"key":"10.1016\/j.ejca.2020.06.005_bib14","doi-asserted-by":"crossref","DOI":"10.3747\/co.25.4208","article-title":"Outcomes by treatment modality in elderly patients with localized gastric and esophageal cancer","volume":"25","author":"Natori","year":"2018","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ejca.2020.06.005_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/bjs.8952","article-title":"Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer","author":"Koppert","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejca.2020.06.005_bib16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4140\/TCP.n.2008.324","article-title":"Pharmacokinetic and pharmacodynamic alterations in the geriatric patient","volume":"23","author":"Delafuente","year":"2008","journal-title":"Consult Pharm"},{"key":"10.1016\/j.ejca.2020.06.005_bib17","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S1470-2045(17)30447-3","article-title":"Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial","volume":"18","author":"Alderson","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2020.06.005_bib18","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C","article-title":"Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations","volume":"73","author":"Mandard","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2020.06.005_bib19","doi-asserted-by":"crossref","DOI":"10.1158\/1055-9965.EPI-11-0246","article-title":"Sex disparities in cancer mortality and survival","author":"Cook","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejca.2020.06.005_bib20","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.ejca.2008.11.008","article-title":"The advantage of women in cancer survival: an analysis of EUROCARE-4 data","volume":"45","author":"Micheli","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2020.06.005_bib21","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2011.38.8751","article-title":"Influence of sex on the survival of patients with esophageal cancer","author":"Bohanes","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2020.06.005_bib22","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/annonc\/mdq067","article-title":"The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trials","volume":"21","author":"Wheatley-Price","year":"2010","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.ejca.2020.06.005_bib23","article-title":"Gender differences in stage-adjusted bladder cancer survival","author":"Mungan","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.ejca.2020.06.005_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/j.1442-2050.2006.00557.x","article-title":"Gender-based analysis of esophageal cancer patients undergoing preoperative chemoradiation: differences in presentation and therapy outcome","author":"Rohatgi","year":"2006","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.ejca.2020.06.005_bib25","doi-asserted-by":"crossref","DOI":"10.21873\/anticanres.11306","article-title":"Gender difference in distribution of estrogen and androgen receptors in intestinal-type gastric cancer","author":"Jukic","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejca.2020.06.005_bib26","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jamaoncol.2018.1080","article-title":"Association of patient sex with chemotherapy-related toxic effects: a retrospective analysis of the PETACC-3 trial conducted by the EORTC gastrointestinal group","volume":"4","author":"Cristina","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejca.2020.06.005_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejca.2019.08.010","article-title":"Influence of sex on chemotherapy efficacy and toxicity in oesophagogastric cancer: a pooled analysis of four randomised trials","volume":"121","author":"Davidson","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2020.06.005_bib28","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2005.03.171","article-title":"Influence of sex on toxicity and treatment outcome in small-cell lung cancer","author":"Singh","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2020.06.005_bib29","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.1200\/JCO.2005.205.60","article-title":"Role of hematotoxicity and sex in patients with Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group","volume":"23","author":"Klimm","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2020.06.005_bib30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.critrevonc.2014.07.005","article-title":"Correlation of cetuximab-induced skin rash and outcomes of solid tumor patients treated with cetuximab: a systematic review and meta-analysis","volume":"93","author":"Abdel-Rahman","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejca.2020.06.005_bib31","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S1470-2045(18)30686-7","article-title":"DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis","volume":"19","author":"Henricks","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2020.06.005_bib32","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.ejca.2014.04.014","article-title":"Review of therapeutic drug monitoring of anticancer drugs part 1 - Cytotoxics","volume":"50","author":"Paci","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2020.06.005_bib33","doi-asserted-by":"crossref","first-page":"99336","DOI":"10.18632\/oncotarget.22242","article-title":"The sexist behaviour of immune checkpoint inhibitors in cancer therapy?","volume":"8","author":"Botticelli","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2020.06.005_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2018-000344","article-title":"Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?","volume":"3","author":"Pinto","year":"2018","journal-title":"ESMO Open"},{"key":"10.1016\/j.ejca.2020.06.005_bib35","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/jnci\/djz094","article-title":"Sex-based heterogeneity in response to lung cancer immunotherapy: a systematic review and meta-analysis","volume":"111","author":"Conforti","year":"2019","journal-title":"JNCI J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2020.06.005_bib36","series-title":"Sex differences in adverse event reporting in SWOG chemotherapy, biologic\/immunotherapy, and targeted agent cancer clinical trials","author":"Unger","year":"2019"},{"key":"10.1016\/j.ejca.2020.06.005_bib37","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.ejca.2015.07.002","article-title":"Impact of age on the feasibility and efficacy of neoadjuvant chemotherapy in patients with locally advanced oesophagogastric cancer","volume":"51","author":"Lorenzen","year":"2015","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2020.06.005_bib38","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ejca.2012.09.025","article-title":"The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: a randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+)","volume":"49","author":"Al-Batran","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2020.06.005_bib39","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1200\/JCO.2019.37.15_suppl.4006","article-title":"Optimizing chemotherapy for frail and elderly patients (pts) with advanced gastroesophageal cancer (aGOAC): the GO2 phase III trial","volume":"37","author":"Hall","year":"2019","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920303373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920303373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:27:40Z","timestamp":1760732860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804920303373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":39,"alternative-id":["S0959804920303373"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2020.06.005","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of sex and age on chemotherapy efficacy, toxicity and survival in localised oesophagogastric cancer: A pooled analysis of 3265 individual patient data from four large randomised trials (OE02, OE05, MAGIC and ST03)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2020.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}